|
|
Volumn 42, Issue 1, 2006, Pages 3-4
|
|
Guest Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHEMOKINE RECEPTOR;
CHEMOKINE RECEPTOR CCR7;
SQUAMOUS CELL CARCINOMA ANTIGEN;
TUMOR MARKER;
SERINE PROTEINASE INHIBITOR;
SQUAMOUS CELL CARCINOMA RELATED ANTIGEN;
SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN;
TUMOR ANTIGEN;
BLOOD LEVEL;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER SCREENING;
CANCER SURVIVAL;
CELL PROTECTION;
CLINICAL EXAMINATION;
EDITORIAL;
HEAD AND NECK CANCER;
HUMAN;
INGUINAL LYMPH NODE;
LYMPH NODE METASTASIS;
MICROMETASTASIS;
MOUTH CANCER;
NECK DISSECTION;
NECK METASTASIS;
PATIENT IDENTIFICATION;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENCE RISK;
SQUAMOUS CELL CARCINOMA;
TONGUE CARCINOMA;
TUMOR CELL;
VULVA CANCER;
BLOOD;
MOUTH TUMOR;
ANTIGENS, NEOPLASM;
CARCINOMA, SQUAMOUS CELL;
MOUTH NEOPLASMS;
PROGNOSIS;
SERPINS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 29244442345
PISSN: 13688375
EISSN: None
Source Type: Journal
DOI: 10.1016/j.oraloncology.2005.06.006 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
